{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:54:50Z","timestamp":1773312890225,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jinf.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T04:21:14Z","timestamp":1289449274000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Rifaximin intake leads to emergence of rifampin-resistant staphylococci"],"prefix":"10.1016","volume":"62","author":[{"given":"Thomas","family":"Valentin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Rohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zollner-Schwetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut J.F.","family":"Salzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2010.11.004_bib1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra035415","article-title":"Treatment of infections associated with surgical implants","volume":"350","author":"Darouiche","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2010.11.004_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.injury.2006.04.003","article-title":"Staphylococci and implant surfaces: a review","volume":"37","author":"Harris","year":"2006","journal-title":"Injury"},{"key":"10.1016\/j.jinf.2010.11.004_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.05.007","volume":"52","author":"Bonow","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jinf.2010.11.004_bib4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.11.004_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jinf.2006.11.011","article-title":"Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis","volume":"54","author":"Daver","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jinf.2008.04.003","article-title":"Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections","volume":"57","author":"Dombrowski","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib7","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/AAC.00343-07","article-title":"In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm","volume":"51","author":"Villain-Guillot","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2010.11.004_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/39.2.235","article-title":"Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin","volume":"39","author":"Drancourt","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/588298","article-title":"Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period","volume":"47","author":"Conen","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2010.11.004_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(00)00299-5","article-title":"Antibiotic resistance in staphylococci","volume":"16","author":"Livermore","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2010.11.004_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2009.12.017","article-title":"Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns","volume":"35","author":"Tupin","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 8","key":"10.1016\/j.jinf.2010.11.004_bib13","doi-asserted-by":"crossref","first-page":"S564","DOI":"10.1086\/432953","article-title":"Poorly absorbed antibiotics for the treatment of traveler\u2019s diarrhea","volume":"41","author":"Taylor","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jinf.2010.11.004_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","article-title":"Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes","volume":"58","author":"Johnson","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2010.11.004_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1746-6342.2006.03218.x","article-title":"Review article: the current pharmacological therapies for hepatic encephalopathy","volume":"25","author":"Bass","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2010.11.004_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2010.11.004_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jinf.2004.05.019","article-title":"Rifaximin\u2013a novel antimicrobial for enteric infections","volume":"50","author":"Huang","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000007297","article-title":"In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species","volume":"46","author":"Marchese","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2010.11.004_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0732-8893(93)90004-Q","article-title":"Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative","volume":"16","author":"Hoover","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/499950","article-title":"Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders","volume":"42","author":"Adachi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib23","article-title":"Performance Standards for antimicrobial susceptibility testing; Eighteenth Informational Supplement","year":"2008","journal-title":"CLSI Document"},{"key":"10.1016\/j.jinf.2010.11.004_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jac\/dkg331","article-title":"Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers","volume":"52","author":"Gustafsson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(96)09229-X","article-title":"Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis","volume":"349","author":"Hoiby","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2010.11.004_bib26","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","author":"De Leo","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jinf.2010.11.004_bib27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jac\/dkn078","article-title":"Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability","volume":"61","author":"Ruiz","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/596315","article-title":"High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital","volume":"48","author":"Curry","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib29","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.00342-08","article-title":"Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile","volume":"52","author":"O\u2019Connor","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17453670710014527","article-title":"Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen","volume":"78","author":"Choong","year":"2007","journal-title":"Acta Orthop"},{"key":"10.1016\/j.jinf.2010.11.004_bib31","first-page":"229","article-title":"Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection","volume":"57","author":"Murillo","year":"2008","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib32","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/AAC.00775-08","article-title":"Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection","volume":"53","author":"Baldoni","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib33","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.00047-09","article-title":"Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin","volume":"53","author":"John","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1469-0691.2008.02663.x","article-title":"Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene","volume":"15","author":"Hellmark","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2010.11.004_bib35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/AAC.01651-07","article-title":"In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci","volume":"52","author":"Robertson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib36","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.38.10.2231","article-title":"Antimicrobial susceptibility of coagulase-negative staphylococci","volume":"38","author":"Archer","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/infdis\/147.4.642","article-title":"Alteration of staphylococcal flora in\u00a0cardiac surgery patients receiving antibiotic prophylaxis","volume":"147","author":"Archer","year":"1983","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib38","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1128\/AAC.47.10.3130-3137.2003","article-title":"Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection","volume":"47","author":"Kadurugamuwa","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2010.11.004_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-8-26","article-title":"Rifaximin for maintenance therapy in antibiotic-dependent pouchitis","volume":"8","author":"Shen","year":"2008","journal-title":"BMC Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2010.11.004_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000089778","article-title":"Treatment of functional bowel disorders: is there room for antibiotics?","volume":"73","author":"Corazza","year":"2006","journal-title":"Digestion"},{"issue":"Suppl. 8","key":"10.1016\/j.jinf.2010.11.004_bib41","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.1086\/432954","article-title":"Antibacterial chemoprophylaxis in the\u00a0prevention of traveler\u2019s diarrhea: evaluation of poorly absorbed oral rifaximin","volume":"41","author":"DuPont","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2010.11.004_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000089780","article-title":"Management of colonic diverticular disease","volume":"73","author":"Frieri","year":"2006","journal-title":"Digestion"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2010.11.004_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000089789","article-title":"Microbial flora in NSAID-induced intestinal damage: a role for antibiotics?","volume":"73","author":"Lanas","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.jinf.2010.11.004_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/432056","article-title":"Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals","volume":"41","author":"MacDougall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2010.11.004_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2009.01.012","article-title":"Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit","volume":"58","author":"Uckay","year":"2009","journal-title":"J Infect"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310003294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310003294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:14:30Z","timestamp":1759007670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445310003294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0163445310003294"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2010.11.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifaximin intake leads to emergence of rifampin-resistant staphylococci","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2010.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}